Kiniksa Pharmaceuticals (KNSA) Stock Chart & Stock Price History → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free KNSA Stock Alerts $19.53 -0.05 (-0.26%) (As of 01:38 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Kiniksa Pharmaceuticals Stock Price Performance5 Day Performance-3.27%1 Month Performance+12.96%3 Month Performance-1.81%6 Month Performance+22.45%Year-To-Date Performance+11.35%1 Year Performance+43.08% Receive KNSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica could fall from this eventAmerica’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. KNSA Stock Chart for Tuesday, May, 14, 2024 KNSA Chart by TradingView Kiniksa Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$19.53$19.58+0.26%$19.90$19.47193,968 shs$1.39 billion05/10/2024$20.19$19.53-3.27%$20.50$19.53333,361 shs$1.39 billion05/09/2024$20.26$20.19-0.35%$20.37$20.00344,658 shs$1.43 billion05/08/2024$20.33$20.26-0.34%$20.38$20.02272,503 shs$1.44 billion05/07/2024$19.99$20.33+1.70%$20.44$19.93332,862 shs$1.44 billion05/06/2024$20.08$19.99-0.45%$20.25$19.90296,252 shs$1.41 billion Get the Latest News and Ratings for KNSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$19.38$20.08+3.61%$20.40$19.63403,798 shs$1.42 billion05/02/2024$19.40$19.38-0.10%$19.75$19.24411,948 shs$1.37 billion05/01/2024$18.72$19.40+3.63%$19.92$18.81579,153 shs$1.37 billion04/30/2024$18.55$18.72+0.92%$18.84$18.26598,807 shs$1.32 billion04/29/2024$17.88$18.55+3.75%$18.65$17.81398,466 shs$1.31 billion04/26/2024$17.61$17.88+1.53%$18.05$17.45331,616 shs$1.26 billion04/25/2024$17.86$17.61-1.40%$18.11$17.50477,276 shs$1.24 billion04/24/2024$17.68$17.86+1.02%$18.59$17.64443,685 shs$1.26 billion04/23/2024$17.10$17.68+3.42%$18.14$17.04611,398 shs$1.25 billion04/22/2024$16.91$17.10+1.09%$17.43$16.87361,003 shs$1.21 billion04/19/2024$16.88$16.91+0.18%$17.15$16.56375,954 shs$1.19 billion04/18/2024$16.95$16.88-0.41%$17.05$16.80409,188 shs$1.19 billion04/17/2024$17.46$16.95-2.92%$17.57$16.92389,307 shs$1.20 billion04/16/2024$17.44$17.46+0.11%$17.61$17.33304,967 shs$1.23 billion04/15/2024$17.29$17.44+0.87%$17.54$17.19314,106 shs$1.23 billion04/12/2024$17.70$17.29-2.32%$17.71$17.13257,002 shs$1.22 billion04/11/2024$17.45$17.70+1.43%$17.84$17.47291,671 shs$1.25 billion04/10/2024$17.73$17.45-1.58%$17.45$17.00399,417 shs$1.23 billion04/09/2024$17.68$17.73+0.28%$18.00$17.52342,701 shs$1.25 billion04/08/2024$17.90$17.68-1.23%$17.86$17.62312,199 shs$1.25 billion04/05/2024$18.06$17.90-0.89%$18.17$17.66251,070 shs$1.26 billion04/04/2024$18.24$18.06-0.99%$18.55$18.02368,541 shs$1.28 billion04/03/2024$18.73$18.24-2.62%$18.61$17.84474,592 shs$1.29 billion04/02/2024$19.70$18.73-4.92%$19.51$18.45425,682 shs$1.32 billion04/01/2024$19.73$19.70-0.15%$19.73$19.20301,525 shs$1.39 billion03/29/2024$19.73$19.73$20.13$19.47359,719 shs$1.39 billion03/28/2024$19.99$19.73-1.30%$20.13$19.47359,619 shs$1.39 billion03/27/2024$19.97$19.99+0.10%$20.16$19.88358,398 shs$1.41 billion03/26/2024$19.96$19.97+0.05%$20.25$19.85406,095 shs$1.41 billion03/25/2024$19.97$19.96-0.05%$20.32$19.66235,457 shs$1.41 billion03/22/2024$19.80$19.97+0.86%$20.12$19.54350,736 shs$1.41 billion03/21/2024$19.78$19.80+0.10%$20.09$19.68424,615 shs$1.40 billion03/20/2024$19.70$19.78+0.41%$19.79$19.15364,687 shs$1.40 billion03/19/2024$19.58$19.70+0.61%$19.84$19.33301,179 shs$1.39 billionLook Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here.03/18/2024$19.99$19.58-2.05%$19.91$19.43360,072 shs$1.38 billion03/15/2024$20.35$19.99-1.77%$20.58$19.93785,820 shs$1.41 billion03/14/2024$20.46$20.35-0.54%$20.37$19.78342,741 shs$1.44 billion03/13/2024$20.44$20.46+0.10%$20.90$20.25416,701 shs$1.44 billion03/12/2024$20.34$20.44+0.49%$20.63$20.09339,222 shs$1.44 billion03/11/2024$20.81$20.34-2.26%$20.91$20.11586,911 shs$1.44 billion03/08/2024$21.26$20.81-2.12%$21.52$20.51304,806 shs$1.46 billion03/07/2024$21.00$21.26+1.24%$21.37$20.65549,178 shs$1.50 billion03/06/2024$20.18$21.00+4.06%$21.00$20.32418,201 shs$1.48 billion03/05/2024$20.19$20.18-0.05%$20.36$19.80369,835 shs$1.42 billion03/04/2024$21.74$20.19-7.13%$22.09$20.00395,182 shs$1.42 billion03/01/2024$21.14$21.74+2.84%$22.08$21.21614,142 shs$1.53 billion02/29/2024$20.36$21.14+3.83%$21.42$20.57558,884 shs$1.49 billion02/28/2024$20.89$20.36-2.54%$21.98$19.20625,836 shs$1.43 billion02/27/2024$20.16$20.89+3.62%$21.11$19.82653,725 shs$1.47 billion02/26/2024$20.00$20.16+0.80%$20.22$19.85250,770 shs$1.42 billion02/23/2024$19.72$20.00+1.42%$20.04$19.74214,144 shs$1.41 billion02/22/2024$19.96$19.72-1.20%$20.05$19.41260,578 shs$1.39 billion02/21/2024$19.92$19.96+0.20%$20.08$19.67200,574 shs$1.40 billion02/20/2024$19.94$19.92-0.10%$20.22$19.69166,738 shs$1.40 billion02/19/2024$19.94$19.94$20.21$19.72203,600 shs$1.40 billion02/16/2024$20.17$19.94-1.14%$20.21$19.72203,662 shs$1.40 billion02/15/2024$19.89$20.17+1.41%$20.51$19.65343,977 shs$1.42 billion02/14/2024$19.86$19.89+0.15%$20.15$19.53177,571 shs$1.40 billion02/13/2024$20.55$19.86-3.36%$20.26$19.56376,055 shs$1.40 billion Related Companies: Arcus Biosciences Stock Price Chart ANI Pharmaceuticals Stock Price Chart Day One Biopharmaceuticals Stock Price Chart Xencor Stock Price Chart Morphic Stock Price Chart Protagonist Therapeutics Stock Price Chart Akero Therapeutics Stock Price Chart Dynavax Technologies Stock Price Chart Gemini Therapeutics Stock Price Chart Ligand Pharmaceuticals Stock Price Chart Receive KNSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KNSA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiniksa Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.